Xin Sun
Director/Board Member at SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.
Xin Sun active positions
Companies | Position | Start | End |
---|---|---|---|
SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. | Director/Board Member | 17/09/2020 | - |
Scivita Medical Technology Co., Ltd.
Scivita Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Scivita Medical Technology Co., Ltd. operates as a medical device company. It engages in the research and development, manufacturing, and commercialization of optical diagnosis and treatment medical devices. The firm’s products include 3D Visualization system and 4K Urtal HD Endoscope System. The company was founded on October 28, 2016 by Yi Zhang and To Chin and is headquartered in Suzhou, China. | Chairman | 22/06/2021 | - |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Director/Board Member | 17/07/2020 | - |
Career history of Xin Sun
Former positions of Xin Sun
Companies | Position | Start | End |
---|---|---|---|
LUYE PHARMA GROUP LTD. | Director/Board Member | 08/02/2021 | 06/12/2023 |
Affinity Equity Partners (HK) Ltd.
Affinity Equity Partners (HK) Ltd. Investment ManagersFinance Affinity Equity Partners (HK) Ltd.(Affinity Equity Partners) is an Independent private equity firm founded in 1998 by Kok Yew Tang. Affinity Equity Partners (HK) Ltd. is headquartered in Korea, Australia, New Zealand, Greater China and Southeast Asia.. | Corporate Officer/Principal | - | - |
Training of Xin Sun
Duke University | Graduate Degree |
Peking University | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Statistics
International
China | 5 |
United States | 3 |
Hong Kong | 3 |
Operational
Director/Board Member | 3 |
Undergraduate Degree | 2 |
Graduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 4 |
Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
LUYE PHARMA GROUP LTD. | Health Technology |
SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. | Health Technology |
Private companies | 3 |
---|---|
Affinity Equity Partners (HK) Ltd.
Affinity Equity Partners (HK) Ltd. Investment ManagersFinance Affinity Equity Partners (HK) Ltd.(Affinity Equity Partners) is an Independent private equity firm founded in 1998 by Kok Yew Tang. Affinity Equity Partners (HK) Ltd. is headquartered in Korea, Australia, New Zealand, Greater China and Southeast Asia.. | Finance |
Scivita Medical Technology Co., Ltd.
Scivita Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Scivita Medical Technology Co., Ltd. operates as a medical device company. It engages in the research and development, manufacturing, and commercialization of optical diagnosis and treatment medical devices. The firm’s products include 3D Visualization system and 4K Urtal HD Endoscope System. The company was founded on October 28, 2016 by Yi Zhang and To Chin and is headquartered in Suzhou, China. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |
- Stock Market
- Insiders
- Xin Sun
- Experience